Clinical trial
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
NCT01624259
Study timeline
Study start (unknown)2012-06-01Date precision: month
Registry last updated2014-10-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Interventions
LY2189265DRUG
LiraglutideDRUG · verified · RxNorm: liraglutide
MetforminDRUG · verified · RxNorm: metformin
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
Los AngelesCalifornia, United States1DallasTexas, United States1MiamiFlorida, United States1San AntonioTexas, United States1BarcelonaSpain1PhoenixArizona, United States1Las VegasNevada, United States1BudapestHungary1PragueCzechia1LouisvilleKentucky, United States1BucharestRomania1Fort LauderdaleFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01624259 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.